Skip to main content
Caplight Logo









iUFlow

iUFlow

Private
MelbourneHealthcare & Life Scienceshttps://iuflow.com

Last Round

Grant

Feb 25, 2020

Total Funding Raised

$370,500

Company Overview

iUFlow operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Grant round in February 2020.

iUFlow is a digital health company that provides a connected bladder monitoring platform, including a wireless home uroflowmeter and a mobile voiding diary app for the diagnosis and management of urological conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Telemedicine, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales, Freemium

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

iUFlow Comparables

Compare iUFlow with similar companies based on industry and business-model similarity.

iUFlow comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Minze Health
87%
iO Urology
83%
UroGenie
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

iUFlow Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 25, 2020
AngelSep 15, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

iUFlow Investors

Notable investors and investment history

iUFlow investors
InvestorRounds
MedTech InnovatorAngel
Sydney AngelsAngel
ArtesianAngel
ANDHealthAccelerator
Australian GovernmentGrant
Melbourne AngelsAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2020

    Received $116K from the Australian Government.

  • Sep 15, 2015

    $253K round with Artesian and MedTech Innovator.

Book a demo to see all signals

For institutional investors. Book with your work email.

iUFlow Filings

Explore SEC and related filing metadata, where available.

iUFlow filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about iUFlow's valuation, stock price, and market status.

Is iUFlow a public or private company?

iUFlow is a private company.

What is the current stock price of iUFlow?

iUFlow is a private company, so its shares have no public market price. Caplight tracks iUFlow's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is iUFlow worth (valuation)?

Valuation information for iUFlow is not publicly available.

Can I buy iUFlow stock?

iUFlow shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was iUFlow's last funding round?

iUFlow's most recent funding round was Grant on February 25, 2020.

Who are the main investors in iUFlow?

Key investors in iUFlow include MedTech Innovator, Sydney Angels, Artesian, ANDHealth, Australian Government.

Will iUFlow IPO soon?

No public IPO plans have been announced for iUFlow.

How can I track iUFlow secondary market activity?

Caplight tracks bids, offers, and trades in iUFlow's shares on secondary markets.

Firmographic Details

HeadquartersMelbourne
Year Founded2015
Last FundingFeb 25, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?